MUC16 and gastric cancer: The somatic mutation analysis highlighted the great majority of mutations in TTN and MUC16 genes in both the high- and low-risk groups, which have been proven to show significant associations with GC prognosis and offer TMB prediction or efficacy prediction in immunotherapy [25].